SPL & Beyond: XML in the Life Sciences

As Structured Product Labeling (SPL) continues to evolve and become adopted throughout the FDA, organizations must ensure their original approach to SPL compliance is the best strategic fit for the enterprise. Initially, the goal for most organizations was focused solely on implementing systems and/or processes to achieve SPL compliance. Depending on your approach, SPL compliance can either result in additional time and cost to the overall submission process, or provide long-term value across the enterprise.

With additional XML-based standards under development, and the ability for structured content to drive efficiencies throughout an enterprise, it is prudent to review your overall approach to structured content authoring and publishing. This presentation looks at how XML can be used to manage content for SPL submissions to the FDA, Product Information Management (PIM) submissions to EMEA, as well as other uses such as standard response letters for customer contact centers.

SPL & Beyond: XML in the Life Sciences was presented by Don Bridges & Joe Jenkins, Commercial Technical Documents Manager, Data Conversion Laboratory (DCL) & Life Sciences Market Director, RWD Technologies and aired on 2006-04-06. For more details, or to download this conference, please visit our site at www.fxconferences.com

State of Readiness? XML in the Life Sciences

The life sciences industry is being thrust into the world of XML. FDA's recently mandated Structured Product Labeling (SPL) initiative as well as private initiatives with Standard Response Letters, Clinical Data, and Product Information Management (PIM) for EMEA labeling have made it clear that the use of XML is on the upswing. But how do you benchmark your organization with your peers? What are the biggest problems in working with documentation?

ForeignExchange Translations, RWD Technologies, and Data Conversion Laboratory asked these questions to a broad cross-section of the life sciences industry through a comprehensive survey. In this presentation we unveil the results, looking at where the industry stands on XML initiatives, and where it needs to be. You learn how your peers are tackling the issues associated with SPL, Standard Response Letters, and Clinical Data Reports. You hear what they report as the biggest problems, and what they are doing to solve them.

State of Readiness? XML in the Life Sciences was presented by Don Bridges, Commercial Technical Documents Manager, of Data Conversion Laboratory (DCL) & Joe Jenkins, Life Sciences Market Director, of RWD Technologies and aired 2006-11-30. For more details or to purchase a download, please visit our site www.fxconferences.com

SPL & Beyond: XML in the Life Sciences

As Structured Product Labeling (SPL) continues to evolve and become adopted throughout the FDA, organizations must ensure their original approach to SPL compliance is the best strategic fit for the enterprise. Initially, the goal for most organizations was focused solely on implementing systems and/or processes to achieve SPL compliance. Depending on your approach, SPL compliance can either result in additional time and cost to the overall submission process, or provide long-term value across the enterprise.

With additional XML-based standards under development, and the ability for structured content to drive efficiencies throughout an enterprise, it is prudent to review your overall approach to structured content authoring and publishing. This presentation will look at how XML can be used to manage content for SPL submissions to the FDA, Product Information Management (PIM) submissions to EMEA, as well as other uses such as standard response letters for customer contact centers.

This audio conference is co-presented by Don Bridges of Data Conversion Laboratory and Joe Jenkins of RWD Technologies. To learn more, visit www.fxconferences.com.